Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections

被引：7

作者：

Macia, M. D.

Mena, A.

Borrell, N.

Perez, J. L.

Oliver, A. ^{[1
]}

机构：

[1] Hosp Son Dureta C Andrea Doria, Serv Microbiol, Inst Univ Invest Ciencias Salud, Palma de Mallorca, Spain

[2] Hosp Son Dureta C Andrea Doria, Unidad Invest, Inst Univ Invest Ciencias Salud, Palma de Mallorca, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 12期

关键词：

D O I：

10.1128/AAC.00981-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：4531 / 4532

页数：2

共 17 条

[1] Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation [J].

Ciofu, O ;

Riis, B ;

Pressler, T ;

Poulsen, HE ;

Hoiby, N .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2276-2282

[2] Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa [J].

Ernst, RK ;

Yi, EC ;

Guo, L ;

Lim, KB ;

Burns, JL ;

Hackett, M ;

Miller, SI .

SCIENCE, 1999, 286 (5444) :1561-1565

[3] Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin [J].

Goldstein, F. W. ;

Ly, A. ;

Kitzis, M. D. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (05) :1039-1040

[4] Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients [J].

Gutiérrez, O ;

Juan, C ;

Pérez, JL ;

Oliver, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3573-3575

[5] PSEUDOMONAS-AERUGINOSA ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS - A CLASS OF SERUM-SENSITIVE, NONTYPABLE STRAINS DEFICIENT IN LIPOPOLYSACCHARIDE-O SIDE-CHAINS [J].

HANCOCK, REW ;

MUTHARIA, LM ;

CHAN, L ;

DARVEAU, RP ;

SPEERT, DP ;

PIER, GB .

INFECTION AND IMMUNITY, 1983, 42 (01) :170-177

[6] Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients [J].

Hogardt, M ;

Schmoldt, S ;

Götzfried, M ;

Adler, K ;

Heesemann, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) :1057-1061

[7] Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis [J].

Hogardt, Michael ;

Hoboth, Christina ;

Schmoldt, Sabine ;

Henke, Christine ;

Bader, Lutz ;

Heesemann, Juergen .

JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (01) :70-80

[8] Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections [J].

Li, Jian ;

Nation, Roger L. ;

Turnidge, John D. ;

Milne, Robert W. ;

Coulthard, Kingsley ;

Rayner, Craig R. ;

Paterson, David L. .

LANCET INFECTIOUS DISEASES, 2006, 6 (09) :589-601

[9] Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections [J].

Maciá, MD ;

Blanquer, D ;

Togores, B ;

Sauleda, J ;

Pérez, JL ;

Oliver, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3382-3386

[10] Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion [J].

Maciá, MD ;

Borrell, N ;

Pérez, JL ;

Oliver, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2665-2672

← 1 2 →